Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000062

Director sold 2,750 shares at $17.29 ($47,548)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Sale : show line 1 in the form −2,750 $17.29 $47,548 139,841 D
Open-market sales · 2,750 sh · avg $17.29 · $47,548
Loading xslF345X05/wk-form4_1708049752.xml…